<div id="readability-page-1"><p><span>Atlassian (NASDAQ:TEAM - Get Free Report)</span> was upgraded by equities research analysts at Wall Street Zen from a &#34;buy&#34; rating to a &#34;strong-buy&#34; rating in a note issued to investors on Saturday.</p><ul><li>These are the 3 Biggest AI Winners and Losers of 2026</li></ul><p>Several other equities research analysts have also recently weighed in on TEAM. Robert W. Baird  set a $120.00 price objective on shares of Atlassian in a research report on Friday, May 1st. Truist Financial raised their price objective on shares of Atlassian from $90.00 to $100.00 and gave the company a &#34;buy&#34; rating in a research report on Friday, May 1st. BNP Paribas Exane assumed coverage on shares of Atlassian in a research report on Monday, March 16th. They issued an &#34;outperform&#34; rating and a $95.00 price objective for the company. Piper Sandler lowered their price objective on shares of Atlassian from $200.00 to $175.00 and set an &#34;overweight&#34; rating for the company in a research report on Friday, May 1st. Finally, BTIG Research raised their price objective on shares of Atlassian from $120.00 to $130.00 and gave the company a &#34;buy&#34; rating in a research report on Thursday. One investment analyst  has rated the stock with a Strong Buy rating, twenty-one have given a Buy rating, five have given a Hold rating and one  has issued  a Sell rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of &#34;Moderate Buy&#34; and a consensus target price of $145.26.</p><p><b>View Our Latest Stock Report on TEAM</b></p><h2>Atlassian Trading Down 0.8%</h2><ul><li>MarketBeat Week in Review – 03/09 - 03/13</li></ul><p>Shares of TEAM stock opened at $91.60 on Friday. Atlassian has a 12-month low of $56.01 and a 12-month high of $232.36. The company has a market capitalization of $24.16 billion, a P/E ratio of -110.36, a P/E/G ratio of 5.24 and a beta of 0.90. The firm has a 50-day moving average price of $72.12 and a 200 day moving average price of $116.37. The company has a quick ratio of 0.89, a current ratio of 0.70 and a debt-to-equity ratio of 1.13. </p><p>Atlassian (NASDAQ:TEAM - Get Free Report) last announced its quarterly earnings results on Thursday, April 30th. The technology company reported $1.75 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.33 by $0.42. The firm had revenue of $1.79 billion during the quarter, compared to the consensus estimate of $1.70 billion. Atlassian had a negative net margin of 3.50% and a positive return on equity of 6.22%. The firm's quarterly revenue was up 31.7% on a year-over-year basis. During the same period last year, the firm posted $0.97 EPS.  Research analysts forecast that  Atlassian will post 0.81 earnings per share for the current fiscal year. </p><h2>Insider Transactions at Atlassian</h2><ul><li>Atlassian's AI Fear Trade May Be Exhausted—3 Signs Point to a Reversal</li></ul><p>In other news, CRO Brian Duffy sold 1,222 shares of Atlassian stock in a transaction that occurred on Thursday, February 19th. The shares were sold at an average price of $81.35, for a total transaction of $99,409.70. Following the completion of the sale, the executive owned 124,332 shares in the company, valued at $10,114,408.20. The trade was a 0.97% decrease in their position. The sale was disclosed in a filing with the Securities &amp; Exchange Commission, which is available through this link. Also, CFO Joseph Leo Binz sold 1,653 shares of Atlassian stock in a transaction that occurred on Thursday, February 19th. The stock was sold at an average price of $81.35, for a total transaction of $134,471.55. Following the sale, the chief financial officer owned 208,639 shares of the company's stock, valued at approximately $16,972,782.65. This represents a 0.79% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 6,013 shares of company stock worth $489,158 in the last quarter. 36.66% of the stock is owned by company insiders. </p><h2>Institutional Investors Weigh In On Atlassian</h2><p>Several institutional investors have recently modified their holdings of the business. Physician Wealth Advisors Inc. grew its position in shares of  Atlassian by 60.4% during the 3rd quarter. Physician Wealth Advisors Inc. now owns 162 shares of the technology company's stock worth $26,000 after buying an additional 61 shares during the period.  GAMMA Investing LLC grew its holdings in  Atlassian by 12.0% during the fourth quarter. GAMMA Investing LLC now owns 615 shares of the technology company's stock valued at $100,000 after purchasing an additional 66 shares during the period.  Snowden Capital Advisors LLC grew its holdings in  Atlassian by 1.6% during the second quarter. Snowden Capital Advisors LLC now owns 4,464 shares of the technology company's stock valued at $907,000 after purchasing an additional 71 shares during the period.  Financial Perspectives Inc grew its holdings in  Atlassian by 11.7% during the fourth quarter. Financial Perspectives Inc now owns 718 shares of the technology company's stock valued at $116,000 after purchasing an additional 75 shares during the period.  Finally, ABN Amro Investment Solutions grew its holdings in  Atlassian by 3.4% during the third quarter. ABN Amro Investment Solutions now owns 2,452 shares of the technology company's stock valued at $392,000 after purchasing an additional 80 shares during the period. Institutional investors and hedge funds own  94.45% of the company's stock. </p><h2>Trending Headlines about Atlassian</h2><p>Here are the key news stories impacting Atlassian this week:</p><ul>   <li><span>Positive Sentiment: </span>Zacks Research upgraded Atlassian from “hold” to “strong-buy,” adding to bullish sentiment around the stock. <i></i><span>Zacks.com</span></li>   <li><span>Positive Sentiment: </span>BTIG Research raised its price target on Atlassian to $130 from $120 and reiterated a “buy” rating, signaling confidence in further upside. <i></i><span>Benzinga</span></li>   <li><span>Positive Sentiment: </span>Barclays lifted its price target to $112 from $106 and kept an “overweight” rating, saying Atlassian’s annual recurring revenue disclosure supports the enterprise growth case. <i></i><span>Article</span></li>   <li><span>Positive Sentiment: </span>Atlassian unveiled “Flex,” a new commercial model designed to help large customers adopt and scale its AI-powered platform more easily, which could improve enterprise sales and retention. <i></i><span>Article</span></li>   <li><span>Positive Sentiment: </span>Atlassian also highlighted new AI-focused products and the expansion of Rovo/Teamwork Graph, reinforcing the narrative that the company is gaining traction in AI-driven workflow automation. <i></i><span>Article</span></li>   <li><span>Neutral Sentiment: </span>Several articles discussed Atlassian’s Team ’26 conference and long-term performance, but these were mostly commentary rather than fresh catalysts. <i></i><span>Article</span></li> </ul><h2>About Atlassian</h2> (Get Free Report)<p>Atlassian Corporation Plc is a software company headquartered in Sydney, Australia, best known for developing collaboration, project management and software development tools. Founded in 2002 by Mike Cannon-Brookes and Scott Farquhar, Atlassian grew from a small engineering-focused team into a publicly traded company after its initial public offering in 2015. The company serves a global customer base that spans small teams to large enterprises across technology, financial services, government and other sectors.  </p><p>Atlassian's product portfolio centers on tools designed to help teams plan, build and support software and business processes.</p><h2>Featured Articles</h2><ul><li>Five stocks we like better than Atlassian</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9VEVBTQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="330" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9VEVBTQ"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Atlassian Right Now?</h2><p>Before you consider Atlassian, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Atlassian wasn't on the list.</p><p>While Atlassian currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

TEAM

CLOU

<p>Wall Street Zen upgraded Atlassian's stock rating from "buy" to "strong-buy". Analysts have set various price targets, with Robert W. Baird at $120, Truist Financial at $100, and BTIG Research at $130. The stock currently has an average rating of "Moderate Buy" and a consensus target price of $145.26. Atlassian reported $1.75 EPS, exceeding estimates, with a revenue of $1.79 billion, up 31.7% year-over-year. The stock opened at $91.60, with a 12-month high of $232.36 and a market cap of $24.16 billion.</p>

Atlassian (NASDAQ:TEAM) Stock Rating Upgraded by Wall Street Zen